Healthcare & Medical
Category / Healthcare & Medical
SHANGHAI: - Patients in the low-dose cohort who have completed 36 weeks of treatment, 9 out of 11 (81.8%) achieved overall clinical remission and 10 out of 11 (91%) achieved immunological complete remission.
- ...
SHANGHAI: SHANGHAI, Dec 2, 2024 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, ...
HONG KONG: - Significantly Boosting Market Penetration and Driving Valuation Reassessment
...
HONG KONG: - Marking Another Milestone in Commercialization
...
HONG KONG: - Demonstrating Benefits of Berberine Ursodeoxycholate (HTD1801)
...
HONG KONG: - Published in "Kidney 360" Magazine
...
HONG KONG: - and with 2024 1H Performance Growing Strongly
- Everest Medicines Showcasing its Industry Leadership ...
TOKYO: Supporting patient comfort, improved diagnostics, and streamlined workflow, available in Europe, parts of Asia and Oceania ...
TOKYO: TOKYO, Sept 20, 2024 - (JCN Newswire) - Olympus Corporation (Olympus), a global MedTech company committed to making people's lives healthier, safer and more fulfilling, announced today the launch ...
SINGAPORE: Strengthens Processes as It Resumes Collection of Cord Blood Units in a Controlled Manner ...
HONG KONG: Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801)
...
HONG KONG: - Dorzagliatin (trade name: HuaTangNing, world's first dual-acting glucokinase activator (GKA), successfully entered China’s National Reimbursement Drug List for Basic Medical Insurance, Work-r ...
Seoul, Korea,: Recognition of Avantor's achievements in downstream processing, single-use systems, and its overall leadership as a biopharma supplier in Korea.
...
